GSK Participates in the British Embassy's "Re-imagining UK Aging Care Event" with a Focus on Enhancing Adult Immunization

Ms. Marija Krstic, General Manager, GlaxoSmithKline (Thailand) Company Limited (GSK), shared that GSK is the leader of research and development in innovative medicines and vaccines globally. The company's vision is to become a leading global biopharma company with a purpose to unite science, technology, and talent to get ahead of diseases together. As a result, GSK is committed to advocating for public awareness regarding the vital role of vaccination in disease prevention. Particularly for the elderly population, who are more vulnerable due to age-related immunity decline, GSK encourages medical consultations to enhance disease understanding and adopt suitable prevention options, thus enhancing their overall quality of life.

"GSK is supporting the British Embassy to host the "Re-imagining UK Aging Care Event," aimed at sharing expertise and establishing benchmarks for elderly care standards. This initiative encompasses advancements in health technology and innovative vaccines, alongside holistic care services emphasizing both mental and physical well-being, with the objective of raising public awareness regarding elderly care in Thailand," said Ms. Krstic.

Within the "Re-imagining UK Aging Care Event", an academic discussion activity was organized on the topics of "What are vaccine-preventable diseases for the elderly and how are they important?" along with "Shaping the Future of Aging Care in Thailand". GSK contributed by setting up a booth covering "The Importance of Adult Immunization" with GSK medical personnel on hand to provide knowledge on promoting adult immunization and vaccine preventable diseases.

HTML::image(

• ข่าว GlaxoSmithKline